ID

36864

Description

Fairly Brief Androgen Suppression and Stereotactic Radiotherapy for High Risk Prostate Cancer - Protocol 2; ODM derived from: https://clinicaltrials.gov/show/NCT02229734

Lien

https://clinicaltrials.gov/show/NCT02229734

Mots-clés

Versions (1)
  1. 17/06/2019 17/06/2019 -
Détendeur de droits

See clinicaltrials.gov

Téléchargé le

17 juin 2019

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Prostate Cancer NCT02229734

Anglais

Eligibility Prostate Cancer NCT02229734

1 Formulaires  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
high risk prostate cancer
Description

High risk Prostate carcinoma

Type de données

boolean

Alias
UMLS CUI [1,1]
C0332167
UMLS CUI [1,2]
C0600139
has had multidisciplinary consultation with radiation oncologist and urologist
Description

Multidisciplinary assessment Radiation Oncologist Urologist

Type de données

boolean

Alias
UMLS CUI [1,1]
C0729737
UMLS CUI [1,2]
C1514693
UMLS CUI [1,3]
C0260314
age >70 or refuses standard treatment
Description

Age | Standard therapy Refused

Type de données

boolean

Alias
UMLS CUI [1]
C0001779
UMLS CUI [2,1]
C2936643
UMLS CUI [2,2]
C1705116
no evidence of extra-prostatic disease on screening bone scan and ct scan (non-contrast ct used for ct simulation acceptable)
Description

Disease Extraprostatic Absent Bone scan | Disease Extraprostatic Absent CT scan

Type de données

boolean

Alias
UMLS CUI [1,1]
C0012634
UMLS CUI [1,2]
C1517078
UMLS CUI [1,3]
C0332197
UMLS CUI [1,4]
C0203668
UMLS CUI [2,1]
C0012634
UMLS CUI [2,2]
C1517078
UMLS CUI [2,3]
C0332197
UMLS CUI [2,4]
C0040405
signed written and voluntary informed consent provided.
Description

Informed Consent

Type de données

boolean

Alias
UMLS CUI [1]
C0021430
patients must be willing and able to comply with scheduled visits, treatment plan, laboratory tests, and other study procedures
Description

Protocol Compliance

Type de données

boolean

Alias
UMLS CUI [1]
C0525058
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
patients not meeting the eligibility criteria
Description

Inclusion criteria failed

Type de données

boolean

Alias
UMLS CUI [1,1]
C1512693
UMLS CUI [1,2]
C0231175
prior pelvic radiotherapy or brachytherapy
Description

Radiotherapy to pelvis | Brachytherapy

Type de données

boolean

Alias
UMLS CUI [1]
C1536155
UMLS CUI [2]
C0006098
use of anti-coagulation (low molecular weight heparin or coumadin)
Description

Use of anticoagulation | Heparin, Low-Molecular-Weight | Coumadin

Type de données

boolean

Alias
UMLS CUI [1]
C0449867
UMLS CUI [2]
C0019139
UMLS CUI [3]
C0699129
history of inflammatory bowel disease, crohn's disease, diverticulitis or collagen vascular disease (other than rheumatoid arthritis)
Description

Inflammatory Bowel Disease | Crohn Disease | Diverticulitis | Collagen-vascular disease | Exception Rheumatoid Arthritis

Type de données

boolean

Alias
UMLS CUI [1]
C0021390
UMLS CUI [2]
C0010346
UMLS CUI [3]
C0012813
UMLS CUI [4]
C0262428
UMLS CUI [5,1]
C1705847
UMLS CUI [5,2]
C0003873
previous treatment for malignancy (other than basal or squamous cell skin cancer) within 3 years of prostate cancer diagnosis
Description

Prior Therapy Malignant Neoplasms | Exception Basal cell carcinoma | Exception Squamous cell carcinoma of skin

Type de données

boolean

Alias
UMLS CUI [1,1]
C1514463
UMLS CUI [1,2]
C0006826
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0007117
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C0553723
patients on androgen deprivation therapy > 2 months prior to study enrolment
Description

Antiandrogen therapy

Type de données

boolean

Alias
UMLS CUI [1]
C0279492
Retour au début de la page

Similar models

Eligibility Prostate Cancer NCT02229734

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
High risk Prostate carcinoma
Item
high risk prostate cancer
boolean
C0332167 (UMLS CUI [1,1])
C0600139 (UMLS CUI [1,2])
Multidisciplinary assessment Radiation Oncologist Urologist
Item
has had multidisciplinary consultation with radiation oncologist and urologist
boolean
C0729737 (UMLS CUI [1,1])
C1514693 (UMLS CUI [1,2])
C0260314 (UMLS CUI [1,3])
Age | Standard therapy Refused
Item
age >70 or refuses standard treatment
boolean
C0001779 (UMLS CUI [1])
C2936643 (UMLS CUI [2,1])
C1705116 (UMLS CUI [2,2])
Disease Extraprostatic Absent Bone scan | Disease Extraprostatic Absent CT scan
Item
no evidence of extra-prostatic disease on screening bone scan and ct scan (non-contrast ct used for ct simulation acceptable)
boolean
C0012634 (UMLS CUI [1,1])
C1517078 (UMLS CUI [1,2])
C0332197 (UMLS CUI [1,3])
C0203668 (UMLS CUI [1,4])
C0012634 (UMLS CUI [2,1])
C1517078 (UMLS CUI [2,2])
C0332197 (UMLS CUI [2,3])
C0040405 (UMLS CUI [2,4])
Informed Consent
Item
signed written and voluntary informed consent provided.
boolean
C0021430 (UMLS CUI [1])
Protocol Compliance
Item
patients must be willing and able to comply with scheduled visits, treatment plan, laboratory tests, and other study procedures
boolean
C0525058 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Inclusion criteria failed
Item
patients not meeting the eligibility criteria
boolean
C1512693 (UMLS CUI [1,1])
C0231175 (UMLS CUI [1,2])
Radiotherapy to pelvis | Brachytherapy
Item
prior pelvic radiotherapy or brachytherapy
boolean
C1536155 (UMLS CUI [1])
C0006098 (UMLS CUI [2])
Use of anticoagulation | Heparin, Low-Molecular-Weight | Coumadin
Item
use of anti-coagulation (low molecular weight heparin or coumadin)
boolean
C0449867 (UMLS CUI [1])
C0019139 (UMLS CUI [2])
C0699129 (UMLS CUI [3])
Inflammatory Bowel Disease | Crohn Disease | Diverticulitis | Collagen-vascular disease | Exception Rheumatoid Arthritis
Item
history of inflammatory bowel disease, crohn's disease, diverticulitis or collagen vascular disease (other than rheumatoid arthritis)
boolean
C0021390 (UMLS CUI [1])
C0010346 (UMLS CUI [2])
C0012813 (UMLS CUI [3])
C0262428 (UMLS CUI [4])
C1705847 (UMLS CUI [5,1])
C0003873 (UMLS CUI [5,2])
Prior Therapy Malignant Neoplasms | Exception Basal cell carcinoma | Exception Squamous cell carcinoma of skin
Item
previous treatment for malignancy (other than basal or squamous cell skin cancer) within 3 years of prostate cancer diagnosis
boolean
C1514463 (UMLS CUI [1,1])
C0006826 (UMLS CUI [1,2])
C1705847 (UMLS CUI [2,1])
C0007117 (UMLS CUI [2,2])
C1705847 (UMLS CUI [3,1])
C0553723 (UMLS CUI [3,2])
Antiandrogen therapy
Item
patients on androgen deprivation therapy > 2 months prior to study enrolment
boolean
C0279492 (UMLS CUI [1])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial